Abstract
The aim of this piece is to estimate the infection fatality rate (IFR) of COVID-19 in Mumbai during 2020, namely the fraction of SARS-CoV-2 infections which resulted in death. The estimates are based on the city’s seroprevalence and fatality data. This task runs into difficulties connected with obtaining reliable estimates of both the numerator (fatalities) and the denominator (infections). In the light of the many uncertainties, it makes most sense to present a range of values with transparent discussion of assumptions and possible biases. We find that the estimates are consistent with meta-analyses of COVID-19 age-stratified IFR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There are no relevant ethical questions requiring approval
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred to in the manuscript is available publicly
